메뉴 열기
메뉴 닫기
메뉴 닫기

最新消息

|

广场消息

更多
Lee & Ko成员
Lee & Ko Welcomes Former Presiding Judge of the Daejeon District Court, Won Jee Jang


Lee & Ko has welcomed Won Jee Jang, who brings extensive trial experience from major courts, including service as a presiding judge at the Daejeon District Court and as a judge at the Seoul Central District Court.

After earning her Bachelor of Laws from Seoul National University in 2007, Ms. Jang entered the legal profession upon completing the Judicial Research and Training Institute (38th) in 2009. She has subsequently managed a wide range of civil and criminal cases across key district courts, beginning at the Gunsan Branch of Jeonju District Court and later serving at the Incheon District Court, Seoul Western District Court, Seoul Central District Court, and Seoul Southern District Court.

From 2022, Ms. Jang served as a judge at the Seoul Central District Court, and from 2024, as a presiding judge at the Daejeon District Court, overseeing numerous complex corporate disputes and significant criminal cases. Her outstanding case management and judicious leadership earned her significant trust both within the judiciary and among external stakeholders.

During her time on the bench, Ms. Jang developed considerable expertise across diverse areas, including civil and criminal litigation, corporate regulation, and family law, demonstrating particular proficiency in handling sophisticated disputes involving corporations and financial institutions. 

At Lee & Ko, Ms. Jang will join the Litigation Group, providing clients with strategic and practical legal services across a wide spectrum of areas, including corporate advisory, civil and criminal litigation, audit and investigation responses, and regulatory risk management.

According to Managing Partner Sanggon Kim, “Ms. Jang is a professional who, drawing on her comprehensive trial background, brings exceptional legal judgment and practical insight, enabling her to deliver trusted legal services to our clients. She will particularly strengthen Lee & Ko’s service quality in complex corporate disputes and risk management.” 

Ms. Jang emphasized, “Building on my judicial service, I aim to assist corporate and individual clients in addressing complex legal risks in a proactive and practical manner. I look forward to collaborating with the experts at Lee & Ko and am committed to providing the highest standard of legal services.”  
 
2026.03.06
Lee & Ko成员
Lee & Ko Announces the Addition of Seung Gyu Lee, Former Head of Legal Department (Vice President) at Samsung SDI


Seung Gyu Lee, former Head of the Legal Department (Vice President) at Samsung SDI, has rejoined Lee & Ko.

Mr. Lee graduated from Seoul National University, College of Law in 1999 and entered the legal profession after completing the Judicial Research and Training Institute (30th) in 2001. He subsequently served as a judge at major courts, including the Seoul Central District Court, Seoul Eastern District Court, Suwon District Court, and Incheon District Court, handling a broad range of civil and criminal cases. 

From 2013, he held the position of professor at the Judicial Research and Training Institute, contributing to the development of junior legal professionals. Between 2014 and 2015, he worked as Judicial Policy Advisor at the National Court Administration, participating in judicial system reforms and policy formulation. From 2016 to 2018, he acted as Presiding Judge at the Suncheon Branch of the Gwangju District Court and the Gwangju Family Court.

From 2020 to 2022, he worked at Lee & Ko, and following his 2022 appointment as Head of the Legal Department (Vice President) at Samsung SDI, he oversaw enterprise-wide legal operations, including contract management, litigation, compliance framework development, intellectual property protection, and global risk management, guiding the company’s key legal strategies. He has been recognized for his exceptional risk management capabilities in advanced industries such as semiconductors, batteries, and automotive electronics.

Mr. Lee rejoins Lee & Ko and will be part of the Litigation Group, providing strategic legal services across a wide spectrum of areas, including corporate advisory, internal investigations, compliance consulting, M&A risk assessment, and civil and criminal litigation strategy.

Managing Partner Sanggon Kim commented, “Mr. Lee is a rare professional with deep expertise in both the legal and industrial sectors. In particular, his experience as a legal head at the global corporation will be a valuable asset to our clients.”

Mr. Lee added, “Through my return to the firm, I aim to contribute to proactively and effectively addressing the complex legal challenges faced by companies.”
 
2026.03.06
Lee & Ko成员
Former FSC Capital Market Investigation Coordination Division Head, Sangrok Shin, Joins Lee & Ko


Sangrok Shin has joined Lee & Ko bringing significant experience in policy development and regulatory enforcement gained through years of service in senior roles at the Financial Services Commission.

At Lee & Ko, Mr. Shin takes a role in the Financial Group, focusing on regulatory consulting, administrative responses, investigations, and litigation for financial institutions, fintech companies, insurance providers, and asset management firms. 

After earning a degree in Public Administration from Yonsei University and a master’s degree from Hanyang University Graduate School, Mr. Shin began his legal career upon completing the Judicial Research and Training Institute (35th). He subsequently served at the National Tax Tribunal of the Ministry of Finance and Economy and at the Tax Tribunal under the Prime Minister’s Office. Beginning in 2012, he spent approximately 14 years at the Financial Services Commission and its affiliated agencies, managing key operational and policy functions and developing deep expertise in financial regulation.

Notably, Mr. Shin held positions at the Financial Services Commission, including Head of the Capital Market Investigation Coordination Division, Head of the Financial Data Policy Division, Head of the Regulatory Enforcement Division at the Korea Financial Intelligence Unit, and Head of the Review Support Team, while also gaining experience in the Insurance Division and the Financial Dispute Response Team. His leadership in major international dispute responses and investigations, including the Lone Star ISDS Case, is expected to serve as a substantial asset in navigating complex regulatory risks for domestic and international financial institutions and corporations. 

Managing Partner Sanggon Kim (Judicial Research and Training Institute, 23rd) commented, “The addition of Attorney Sangrok Shin further enhances the capabilities of Lee & Ko’s Financial Group. His firsthand insights from policy implementation and practical expertise offer a valuable opportunity to provide clients with even more sophisticated legal services. In particular, bringing such talent on board is exceptionally timely, as the increasingly complex financial regulatory environment demands proactive and strategic responses.”
 
2026.03.05
Lee & Ko成员
Former Compliance Officer and Vice President of Samsung C&T, Hyun Dong Lee, Assumes a Role at Lee & Ko


Lee & Ko has appointed Hyun Dong Lee, who offers substantial practical experience in corporate compliance and criminal advisory. 

Mr. Lee graduated from Seoul National University, College of Law and completed the Judicial Research and Training Institute (19th). He later served as a prosecutor at the Busan, Seoul, and Incheon District Prosecutors’ Offices, where he developed expertise in investigations and criminal justice. He further broadened his global legal perspective through advanced studies at the University of Michigan Law School and Duke University School of Law (LL.M.).

After joining Samsung Group in 2000, Mr. Lee held several senior positions, including Executive Director of the Corporate Restructuring Headquarters, Senior Executive Director of the Group Legal Office, and Vice President, where he was responsible for developing key group-level legal strategies and overseeing risk management. In particular, he played a pivotal role in establishing the compliance framework—one of the core pillars of ESG management—thereby contributing significantly to the embedding of a culture of compliance across Samsung Group.

Beginning in 2016, he acted as Vice President and Head of the Compliance Management Office at Samsung Heavy Industries, and from 2020, he assumed the role of Compliance Officer at Samsung C&T, making significant contributions to enhancing the group’s overall compliance standards.

Mr. Lee will become a member of Lee & Ko’s Corporate Advisory Group, where he will concentrate on advising across the full spectrum of compliance matters, including internal investigations, anti-bribery measures, governance framework development, criminal risk management, and responses to audits and regulatory inquiries. He will place particular emphasis on delivering practical, actionable solutions tailored to the complex regulatory environments confronting multinational corporations and large business groups. 

Managing Partner Sanggon Kim (Judicial Research and Training Institute, 23rd) commented, “Mr. Lee is a rare practitioner who has advanced compliance not merely as legal advice, but as an integral component of corporate management strategy. As governance expectations rise for both domestic and international companies, his knowledge and insights will provide substantial value to our clients.”

Mr. Lee added, “Building on my background as a corporate lawyer, I aim to strengthen practical support across the firm to help companies achieve trusted and responsible management. Together with Lee & Ko, I look forward to leading the delivery of legal services that promote sustainable growth and foster transparent corporate governance.” 
 
2026.03.05
荣誉
Chambers Global 2026 - Band 1 in 6 practice areas
Lee & Ko has been recognized once again in the 2026 Chambers Global Guide, securing Band 1 rankings in six practice areas and confirming its top-tier law firm status. As for the individual rankings, 37 attorneys of Lee & Ko have been recognized as leading lawyers for their remarkable performance in their respective practice areas.

Firm Rankings
 Banking & Finance  
 Capital Markets  
 Corporate/M&A  
 Intellectual Property 
 International & cross Border Capabilities: South Korean Firms
 International Trade 

Ranked Lawyers
 Banking & Finance: Yeo Kyoon Yoon, Woo Young Jung, Yong-Jae Chang, Myoung Chul Kwak, Dong Seok Woo
 Capital Markets: Hyunjoo Oh, Seunga Hyun, Jun Woo Cho 
 Capital Markets: Securitisation: Jin Hong Kwon
 Corporate/M&A: Sanggon Kim, Ho Joon Moon, Hyeong Gun Lee, Yong Joon Yoon, Daehoon Koo
 Dispute Resolution: Arbitration: Saemee Kim, Zachary Sharpe, Sanghoon Han, Grace Yoon
 Dispute Resolution: Litigation: Pyoung Keun Song, Dajoo Jung, Seon Tae Kim, Jae Heon Park
 IP: Un Ho Kim, Keum Nang Park, Hyeon Gil Ryoo, Vera Eun Woo Lee, Hankil D. Kang, Hwansung Park, Jaewoo Kwak
 International Trade: Kichang Chung, Hyunsoo Joo, Young Gee Park, Young Jae Cho, Heysoo Kim 
 North Korea - general business law: Hyung Sub Lim (Foreign Expertise based abroad in South Korea)


Chambers Global Guide is a law firm evaluation publication released by Chambers and Partners, a leading global legal publisher based in England, which selects top law firms and top lawyers in the Asia-Pacific region each year based on a comprehensive analysis of data submitted by law firms, interviews with partner lawyers and clients, and recently accomplished work.

 
2026.02.13
研讨会/活动
Seminar on "2026 Outlook for the Korean Commercial Real Estate Market."
On February 11, 2026, Lee & Ko hosted a seminar on “2026 Outlook for the Korean Commercial Real Estate Market.”

The seminar covered global capital flow trends and changes in the macroeconomic and interest rate environment, and their implications for investment conditions in the Korean commercial real estate market. The speakers provided an overview of how shifting capital market dynamics are expected to influence investor sentiment, asset allocation strategies, and overall market outlook in 2026.

The seminar also addressed key legal and practical considerations associated with the increasing diversification of real estate investment portfolios. In addition, the speakers also discussed recent regulatory and policy developments in the corporate rental housing sector, offering practical insights into emerging legal issues and key considerations for investors navigating the changing regulatory landscape.
2026.02.13

媒体中心

更多
[The Seoul Shinmun] “Former Police” Get the “Former Bench” Treatment: Law Firms Vie for Police Talent at a Premium [Changes in Seocho-dong amid Judicial and Prosecutorial Reform]
On March 17, 2026, The Seoul Shinmun published a feature examining, “As criminal investigations have increasingly gravitated toward the police and away from the prosecution after the realignment of investigative authority, a shift is now rippling through the legal profession.” In support of this observation, it further mapped the current footprint of former law enforcement across the five largest law firms in Korea, with approximately 140 former officers now in practice, led by Kim & Chang at roughly 60, followed by Lee & Ko at 25, Yulchon at 22, Bae, Kim & Lee at 18, and Shin & Kim at 17.
2026.03.17
[JoongAng Ilbo] Lee & Ko Wins NDMA-related Unjust Enrichment Lawsuit Against the National Health Insurance Service
On January 27, 2026, JoongAng Ilbo reported that Lee & Ko, representing pharmaceutical companies, prevailed in an unjust enrichment lawsuit against the National Health Insurance Service (NHIS) concerning NDMA (N-nitrosodimethylamine)-related pharmaceutical impurities. The article noted that the ruling, issued on January 16, 2026, by the Seoul Central District Court at the first-instance level, has drawn significant attention within the industry, as Lee & Ko successfully obtained a favorable judgment in the unjust enrichment action filed against the NHIS in connection with NDMA-related impurities.

According to JoongAng Ilbo, the court held that “even if impurities are detected in a pharmaceutical product, the health authorities cannot impose re-prescription or re-dispensing costs on pharmaceutical companies, provided there is no manufacturing or quality control negligence on the part of the company and no harm to human health.” The article further explained that “the court ruling departs from prior decisions in similar cases, where courts had broadly deferred to the professional discretion of health authorities and found pharmaceutical companies liable.”
2026.01.27
[Daily Pharm] Unprotected Drug Price Cuts Threaten Pharmaceutical Industry Sustainability...
On January 22, 2026, Daily Pharm published a detailed report on the participation of Chung Jin Hwan, an attorney at Lee & Ko, in the 55th Future Forum held under the theme “How We Should Position Ourselves in the Era of Major Drug Pricing Reform.” At the forum, Chung presented both legal and industrial analysis of the drug pricing reform proposal announced by the Ministry of Health and Welfare last November. He expressed concerns about the government’s proposal to lower the generic drug pricing benchmark from the current 53.55% to the 40% range, noting that “while the government cites Japan and France as reference cases, it remains open to question whether a horizontal comparison is appropriate given differences in industrial structure and the proportion of globally innovative drugs in those markets.” Attorney Chung further emphasized the need to carefully examine whether the proposed reduction to the 40% range is supported by a sound rationale, particularly in terms of how such a cut would contribute to promoting new drug development by domestic pharmaceutical companies.
2026.01.22
[The Asia Business Dailey] [Law Firm Now] Lee&Ko Successfully Concludes Seminar on Analysis and Outlook of Yellow Envelope Act Enforcement Decree and Interpretation Guidelines
On January 9, 2026, The Asia Business Dailey reported on the client seminar titled “Analysis and Outlook on the Amended Enforcement Decree and Interpretive Guidelines of the Trade Union and Labor Relations Adjustment Act,” hosted by Lee&Ko. According to the article, the seminar was organized to provide a clear and accessible explanation of the interpretative guidelines and proposed amendments to the Enforcement Decree of the Trade Union and Labor Relations Adjustment Act (the so called “Yellow Envelope Act”), which were announced by the Ministry of Employment and Labor at the end of last year and are scheduled to be implemented on March 10. The Seminar aimed to offer practical guidance to corporate representatives preparing for the new regulatory framework.

The article further noted that the seminar attracted more than 1,000 participants, reflecting the high level of interest among companies in the upcoming legislation.
2026.01.09

最新案例

更多
Lee & Ko Advises Korean Consortium on USD 1.3 Billion Financing of Panama Metro Tunnel
Lee & Ko has advised the Korean consortium (as borrower) comprised of Hyundai Engineering & Construction Co., Ltd., POSCO Eco & Challenge Co. Ltd. and Hyundai Engineering Co., Ltd., in connection with the consortium’s Syndicated Discounted Repurchase Facility financing for the construction of the Panama Metro Line 3. 

The financing was structured as a securitization of government payment certificates (Certificados de No Objeción, or CDNOs) via three separate facilities provided by KEXIM, IDB Invest (the private sector arm of the Inter-American Development Bank), and a syndicate of seven international banks covered by K-Sure.

The funding will be used by the consortium to extend the Panama Metro Line 3 under the Panama Canal and further demonstrates the trust that international financiers place in the technical expertise of Korean contractors exporting their skills and know-how worldwide. 
2026.01.30
Lee & Ko Secures Full Victory for Korean Entertainment Company in SHIAC Arbitration against Chinese Firm
Lee & Ko successfully represented a prominent Korean entertainment company in an international arbitration administered by the Shanghai International Arbitration Center (“SHIAC”) against a Chinese software company, securing a full award in favor of the client. The dispute arose from a licensing agreement under which the Korean entertainment company granted the Chinese firm the right to develop games utilizing the intellectual property of its affiliated artists. The case involved complex factual and legal contentions, centered primarily on the attribution of liability for significant development delays and the fulfillment of contractual conditions for termination.

As the governing law of the contract was Chinese law, the case demanded a meticulous and nuanced analysis of the local legal framework and contract law principles. Furthermore, because both the seat of arbitration and the arbitral institution were located in China, the proceedings required extensive experience and strategic expertise in navigating the specific procedural nuances of Chinese international arbitration.

Leveraging its deep track record of handling high-stakes disputes in China, Lee & Ko’s International Arbitration Team acted as sole counsel throughout the proceedings. The team successfully led all written submissions and hearing proceedings against local Chinese counsel, ultimately securing a "complete victory" for the client. This outcome underscores Lee & Ko’s dominant capability in China-related disputes and its proven ability to deliver favorable results in challenging foreign jurisdictions.
2025.12.16
Full Acquittal on Appeal in Prosecution for Violation of the Serious Accidents Punishment Act
Lee & Ko represented SK Multi Utility Co., Ltd. (a power generation subsidiary of SK Chemicals), together with its Chief Executive Officer and Plant Manager, in a criminal prosecution alleging violations of the Serious Accidents Punishment Act (“SAPA”) and the Occupational Safety and Health Act (“OSHA”) arising from a fatal accident at a coal unloading facility involving an employee of a contractor. Following a full acquittal at first instance, Lee & Ko secured dismissal of the prosecution’s appeal, and the appellate court affirmed the acquittal in full.

On December 20, 2022, at a coal unloading facility of Company A, a dump truck loaded with coal overturned during the unloading process when the driver, employed by a transportation company, raised the truck bed without opening the rear gate. A contractor employee who was present at the site was crushed by the coal and the vehicle and died.

The appellate court held that a causal link could not be established between the fatal accident and the alleged breaches, including an alleged failure to protect workers from falling-object hazards and an alleged failure to establish an adequate safety and health management system under SAPA. The court further reasoned that, where the accident was clearly attributable to the driver’s operational error, imposing criminal liability on management solely by reason of the occurrence of the harmful result would be unwarranted, underscoring that SAPA does not impose strict result-based liability.

In circumstances where there were no settled judicial principles on causation under SAPA, Lee & Ko conducted a detailed analysis of the accident mechanism and surrounding facts, and presented a reasoned case that criminal liability requires proof of causation between any breach of statutory safety and health obligations and the fatal outcome.

This judgment is expected to serve as an important reference point in assessing causation in ongoing SAPA prosecutions and in future cases arising from fatal industrial accidents.
2025.12.11
LG Chem’s sale of its Water Solutions Business
On June 13, 2025, LG Chem entered into a Business Transfer Agreement to sell its Water Solutions business to Korea Water Solution Holdings, a subsidiary of Glenwood Private Equity, with the rights and obligations of the business subsequently transferred to NanoH2O, Inc. As legal counsel to LG Chem, Lee & Ko successfully provided comprehensive legal services throughout the entire process leading to the successful closing of the transaction.

This carve-out transaction involved significant complexities, as the seller was required not only to divide and transfer part of the site it currently occupies but also to transfer contracts, workforce, licenses, assets, rights, and obligations on a detailed, item-by-item basis. Additionally, to ensure a smooth transition, both parties had to agree on various operational matters, such as joint use of facilities, utility supply, and transition support.

Throughout the process, Lee & Ko provided swift and effective legal counsel on issues ranging from the division and sale of the factory site, the review of regulatory requirements for business and environmental permits, to negotiating and executing ancillary agreements essential for the seamless execution of the business transfer. The firm’s prompt and strategic advice played a critical role in the successful completion of the transaction.
 
2025.12.01
Representation in an International Dispute Concerning a Medical Device Supply Agreement
Lee & Ko is representing a Taiwanese medical device supplier in appellate proceedings arising from an international civil dispute against a Korean diagnostic kit manufacturer in connection with a medical device supply agreement.

The dispute concerns the supply of COVID-19 antigen rapid diagnostic test kits to the Taiwanese market during the COVID-19 pandemic. The key issues include performance of contractual obligations, alleged deficiencies in product performance, and the corresponding scope of payment obligations under the agreement. In the first instance, the court ruled against the supplier, finding that no defect in the rapid diagnostic kits had been established. Following its appointment at the appellate stage, Lee & Ko has undertaken a comprehensive review of the trial court’s reasoning and overall analytical framework.

In the appellate proceedings, Lee & Ko is addressing not only issues of contractual interpretation relating to claims for payment, but also a range of complex legal and technical questions. These include applicable medical device performance standards, the adequacy of quality management systems, and the extent to which actions taken by overseas regulatory authorities may influence the assessment of civil liability.

Drawing on its understanding of Taiwan’s regulatory framework and academic environment, the firm has worked in close coordination with local regulatory and academic experts to obtain authoritative expert opinions. These materials have been carefully integrated into the appellate strategy to ensure that the court is presented with a scientifically grounded and legally coherent analysis.

This case represents a multifaceted cross-border dispute involving international distribution arrangements, product performance issues, and foreign regulatory considerations. In the appellate proceedings, Lee & Ko is systematically organizing both the factual record and the governing legal principles, and advancing persuasive arguments from legal and technical perspectives to support a reasoned and balanced determination.
 
2025.11.28
Lee & Ko Represents Alvogen in Multinational Pharmaceutical Collusion Investigation; Secures Partial Victory on Appeal
Lee & Ko represented Alvogen in an investigation by the Korea Fair Trade Commission (“KFTC”) concerning alleged collusion between Alvogen and AstraZeneca relating to certain oncology drugs.

Following a three-year investigation, the KFTC issued an Examiner’s Report in June 2022 concluding that Alvogen’s agreement not to produce and sell generic versions of Zoladex, Casodex, and Arimidex (collectively, “DEX Drugs”) in exchange for exclusive distribution rights for AstraZeneca’s products constituted unlawful collusion. The KFTC imposed corrective measures, an administrative fine, and referred the matter for potential criminal prosecution.

In response, Lee & Ko, together with its in-house Competition Economics Consulting Group (CECG), submitted detailed economic and legal analyses arguing that (i) delays in generic development were attributable to the inherent scientific and technical complexities of oncology drug development, (ii) the grant of exclusive distribution rights was consistent with ordinary industry practice, and (iii) no economic compensation was exchanged for restricting competition, such that the arrangement did not constitute a “reverse payment” agreement.

As a result, the KFTC reduced the applicable surcharge rate to 3% (from the initially suggested 5–7%), imposed an administrative fine of approximately KRW 1.2 billion, and exempted Alvogen from criminal referral.

In subsequent administrative litigation before the Seoul High Court, Lee & Ko successfully challenged the KFTC’s findings with respect to Casodex and Arimidex. Although the court acknowledged the existence of certain agreements, it held that their anticompetitive effects had not been established. The court therefore overturned the KFTC’s decision with respect to those two products. With respect to Zoladex, the court concluded that the administrative fine could not be independently calculated, resulting in the cancellation of the related corrective orders and the entirety of the administrative fine.

The decision is significant in that, although collusion was recognized for one product, all administrative fines were ultimately cancelled. It represents an important precedent concerning non-compete arrangements in the pharmaceutical sector.
 
2025.11.13
Patent Strategy in the Cosmetics Industry: Implications of a No-Glue Artificial Eyelash Patent Dispute
The IP & Technology Practice Group of Lee & Ko is representing the patentee of a core patent relating to no-glue artificial eyelashes in preliminary injunction proceedings against multiple companies in Korea that manufacture and sell competing products.

In response, the accused companies have initiated multiple actions before the Korean Intellectual Property Office (“KIPO”), including invalidation trials and trials for confirmation of the scope of patent rights. As a result, civil and administrative proceedings are progressing in parallel. Lee & Ko is leading the overall litigation and trial strategy on behalf of the patentee, encompassing preliminary injunction applications, merits litigation, and patent trial proceedings.

The dispute presents intertwined technical and legal issues concerning a new category of cosmetic products—no-glue artificial eyelashes. A central question is whether specific technical features, such as the extent and method of adhesive application and the mechanism by which the product attaches to a user’s natural eyelashes, fall within the scope of the asserted patent claims.

At the preliminary injunction stage, the patentee must establish a prima facie case of infringement and demonstrate the likelihood of irreparable harm through detailed technical analysis. In the parallel patent trial proceedings, the strategic focus is on defending the patent’s validity, particularly the inventive step of the claimed invention over prior art, and articulating a consistent and legally sound interpretation of claim scope.

As Korean cosmetic brands continue to expand globally amid the prominence of “K-beauty,” the industry is characterized by short product life cycles and the rapid emergence of competing and imitative products. In this environment, early-stage patent registration and proactive enforcement are critical to maintaining competitive advantage. This dispute highlights the importance of promptly enforcing registered patent rights while simultaneously clarifying and reinforcing claim scope through coordinated litigation and administrative proceedings. It provides meaningful guidance for companies in the cosmetics sector in developing effective patent strategies and managing IP disputes.
2025.11.11

简讯

更多

检索

更多